Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The goal of Part 1 of this clinical research study is to find the highest tolerable dose of APX005M that can be given with pembrolizumab that can be given to patients with metastatic melanoma. The goal of Part 2 of this study is to learn if the combination can help to control metastatic melanoma. The safety of this drug combination will also be studied.
Critère d'inclusion
- Melanoma